Table 6.
Short term (median 40 days) regression and progression in HbA1c based glycemic categories between paired baseline data in 2,208 participants with an elevated initial baseline fasting plasma glucose or HbA1c.
| Repeat baseline sample category | ||||
|---|---|---|---|---|
| Normal | Non diabetic hyperglycema | Type 2 diabetes | Total | |
| Baseline first HbA1c category | ||||
| Normal (HbA1c 6%, <42 mmol/mol)a | 268 (76.4%) | 83 (23.6%) | 0 (0%) | 351 |
| Non diabetic hyperglycemia (NDH)b | 312 (21.3%) | 1047 (71.6%) | 104 (7.1%) | 1463 |
| Type 2 diabetesb | 1 (0.3%) | 82 (20.8% | 311 (78.9%) | 394 |
aSome participants with normal HbA1c (<6%, <42 mmol/mol) are included as also had an elevated fasting plasma glucose (≥6.1 mmol/L) on same sample. Please note final total sample size is lower than in Tables 1–3 as repeat sample not always undertaken as outlined in methods.
bNDH defined as HbA1c ≥6.0%–6.5 (≥42 to <48 mmol/mol) and Type 2 diabetes defined as HbA1c ≥6.5% (≥48 mmol/mol).
Median time between paired baseline samples was 40 days (interquartile range 27–69 days). Data shown as n and % for each row.